News & Opinions Home

Rural
Economy
Property
Small Business
Trade News
Company News
Forex News
Industry
Local Providers
Regional

Market Place

Business > News & Opinions > Business Wire >

Business Wire

Research and Markets: The Philippine Pharmaceutical Market Was Valued At US$1.4 Billion in 2008, Which Was Equal to Nearly US$15 Per Capita

Saturday May 30, 01:41 AM

Print This Story RSS

Research and Markets(http://www.researchandmarkets.com/research/063ddd/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Philippines" report to their offering.
Changes to be brought by the controversial Cheaper Medicine Bill will impact the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Changes to be brought by the controversial Cheaper Medicine Bill will impact the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. The market is expected to be especially volatile in the short term.
The government has been criticised in the past for not doing enough to promote generics and has recently stepped up its efforts, launching Project 100 in 2008 for example, which promises to offer cheap generics at 100 public hospitals around the country. Parallel imports have increased and the government has urged retailers and wholesalers to stock more generics, as part of its campaign to reduce the price of many essential medicines.
The Philippines is one of the poorer countries in the ASEAN region, with GDP per capita estimated at just US$1,520 in 2009. Health expenditure is also low, both in absolute terms and as a percentage of GDP. The country attracts a degree of overseas aid, although it is reportedly a difficult place in which to undertake healthcare projects.
Administration of the health sector is highly devolved to local government units. This can make planning and co-ordination difficult. Between 50% and 60% of healthcare expenditure and provision is in the private sector. An exodus of medical staff overseas in pursuit of better wages and working conditions has put severe pressure on healthcare services. The Philippines has around 1.1 doctors per thousand population.
The Philippine pharmaceutical market is valued at US$1.4 billion in 2008, equal to nearly US$15 per capita. In terms of the overall market this is comparable to Pakistan and Thailand, and in per capita terms similar to China and Iran.
Key Topics Covered:
EXECUTIVE SUMMARY
Introduction
Pharmaceutical Market Analysis
Pharmaceutical Regulatory Analysis
National Drug Policy
Pharmaceutical Distribution
DIRECTORY
Methodology & Sources
List of Tables
Summary of Key Data Projections, 2008-2013
Summary of the Philippines Pharmaceutical Market, 2008
Market Projections, 2008-2013
SWOT Analysis of the Philippines Pharmaceutical Market, 2009
Imports of Pharmaceuticals by Category, 2002-06 (US$000s)
Import Trends
Leading Suppliers of Raw Materials, 2006 (US$000s)
Leading Suppliers of Medicaments, 2006 (US$000s)
Prices of Parallel Imported Medicines (Pesos) 2008
Registered Drug Manufacturers, 1994-2003
Registered Drug Manufacturers and Traders by Region, 2003
PHAP Members 2009
Exports of Pharmaceuticals, 2002-06 (US$000s)
Export Trends
Leading Destinations, 2006 (US$000s)
Registered Pharmaceutical Suppliers, 1994-2003
Drug Wholesalers/Retailers by Region, 2003
Summary of Demographic Data, 2005/2007
Projected Population, 2008-2013
Healthcare Expenditure, 2005
Projected Health Expenditure, 2008-2013
Hospitals & Beds, 2005
Hospital Bed Projections, 2008-2013
Projected Number of Physicians, 2008-2013
For more information visit http://www.researchandmarkets.com/research/063ddd/the_pharmaceutical
Source: Espicom Business Intelligence Ltd

Contact:Research and MarketsLaura WoodSenior ManagerFax from 
      USA: 646-607-1907Fax from rest of the world: +353-1-481-1716press@researchandmarkets.com

Print This Story RSS

Next Article: Research and Markets: Australia Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2015
Previous article: Research and Markets: 1Q 2009 Report Finds That In the Fourth Quarter of 2008, the Industry Still Managed To Achieve Nearly 30% Year-On-Year Growth

Search:
Advertise with us | Privacy Policy | Terms of Service | Help
Copyright © 2009 Yahoo! All rights reserved.
Yahoo!Xtra: A Yahoo!7/Telecom New Zealand Company.